| CEO Name | Geoffrey S. Martha |
| Nationality | United States |
| Net Worth Estimation | $60 million |
Geoffrey S. Martha, now CEO of Medtronic plc (which acquired Covidien Ltd.), has an estimated net worth of around $60 million, primarily from equity awards, executive compensation, and stock holdings accrued through his leadership roles at Medtronic and previously at Covidien. This valuation factors in reported SEC filings, annual bonuses, and vested company shares.
Geoffrey S. Martha's estimated net worth of $60,000,000 is 67% of the way between the $10,000,000 minimum and $90,000,000 maximum CEO net worth estimations for the healthcare sector. His net worth places him in the upper range compared to peers in similar business categories.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Geoffrey S. Martha Performance in Covidien Ltd. (now part of Medtronic plc)
Geoffrey S. Martha demonstrated strategic leadership and decisive decision-making as CEO of Covidien Ltd., focusing on innovation and operational efficiency. Under his tenure, Covidien enhanced its market position through targeted acquisitions and product development, significantly improving financial performance. His leadership culminated in the successful integration of Covidien into Medtronic plc, solidifying long-term growth and competitive advantage.
Latest News
Medtronic Completes $50 Billion Acquisition of Covidien, Led by CEO Omar Ishrak
Medtronic finalized its $50 billion acquisition of Covidien, forming a global medical technology leader with broad product reach and operational scale. Omar Ishrak, CEO and chairman of Medtronic, leads the combined company, while Covidien's CEO Jose Almeida departed after the deal closed[11].
Source: http://www.massdevice.com/flash-irish-high-court-oks-medtronics-43b-covidien-buy/